The items listed below should be considered by the Meeting in 2004 and 2005. The compounds listed include those recommended as priorities by the CCPR at its 35th, 36th or earlier Sessions and compounds scheduled for re-evaluation within the CCPR Periodic Review Programme.
2004 JMPR
|
Toxicological evaluations |
Residue evaluations |
|
|
|
|
New compounds |
New compounds |
|
fludioxinil |
fludioxinil |
|
trifloxystrobin |
pyraclostrobin |
|
|
Trifloxystrobin |
|
|
|
|
Periodic re-evaluations |
Periodic re-evaluations |
|
glyphosate (158) |
ethoprophos (149) |
|
phorate (112) |
metalaxyl-M |
|
pirimicarb (101) |
paraquat (057) |
|
Propiconazole (160) |
prochloraz (142) |
|
triadimefon (133) {should be evaluated |
Propineb |
|
triadimenol (168) {together |
|
|
|
|
|
Evaluations |
Evaluations |
|
bentazone (172) - acute toxicity |
chlorpyrifos (017) |
|
captan (007) - acute toxicity |
dithiocarbamates (105) |
|
dimethipin (151) - acute toxicity |
Fenitrothion (037) |
|
fenpropimorph (188) - acute toxicity |
folpet (041) |
|
fenpyroximate (193) - acute toxicity |
malathion (047) |
|
folpet (041) - acute toxicity |
methomyl (094) |
|
|
oxydemeton-methyl (166) |
|
|
spinosad (203) |
2005 JMPR
|
Toxicological evaluations |
Residue evaluations |
|
|
|
|
New compounds |
New compounds |
|
dimethenamid-P |
dimethenamid-P |
|
fenhexamid |
fenhexamid |
|
indoxacarb |
indoxacarb |
|
novaluron |
novaluron |
|
|
|
|
Periodic re-evaluations |
Periodic re-evaluations |
|
benalaxyl (155) |
alpha and zeta cypermethrin |
|
clofentezine (156) |
cypermethrin (118) |
|
cyhexatin (067)/azocyclotin (129) |
cyhexatin (067)/azocyclotin (129) |
|
propamocarb (148) |
endosulfan (032) |
|
|
glyphosate (158) |
|
|
methoprene (147) |
|
|
phorate (112) |
|
|
terbufos (167) |
|
|
|
|
Evaluations |
Evaluations |
|
carbendazim (072)-acute toxicity |
ethoxyquin (035) |
|
chlorpropham (201) |
guazatine (114) |
|
ethoxyquin (035) |
methiocarb (132) |
|
guazatine (114) |
|
|
haloxyfop (194) |
|
|
imazalil (110) -acute toxicity |
|
|
thiabendazole (065) |
|
